ADVENTHEALTH CARROLLWOOD
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.1M
- Transactions
- 2,375
- Companies
- 40
- Average per transaction
- $883
Who reported the payments
| AbbVie | $286,916 |
| Biotronik Inc. | $272,641 |
| Boston Scientific | $204,474 |
| Eli Lilly | $191,780 |
| UCB SA | $145,462 |
| Stryker | $131,831 |
| Pfizer | $66,044 |
| Astrazeneca UK Limited | $64,106 |
| Novartis | $56,922 |
| Ethicon Endo-surgery Inc. | $56,367 |
| Centinel Spine, LLC | $54,642 |
| CSL Behring | $54,110 |
| Takeda Pharmaceuticals U.S.A., Inc. | $53,053 |
| Acell, Inc. | $47,736 |
| Johnson & Johnson | $44,750 |
| E.r. Squibb & Sons, L.L.C. | $41,401 |
| Amgen | $37,932 |
| Covidien LP | $30,000 |
| Teva Pharmaceuticals USA, Inc. | $27,109 |
| Surmodics, Inc. | $23,763 |
| Penumbra, Inc. | $20,447 |
| Janssen Research & Development, LLC | $20,148 |
| Sanofi US Services Inc. | $17,248 |
| Inari Medical, Inc. | $16,400 |
| Acadia Pharmaceuticals Inc | $13,864 |
| Carlsmed, Inc. | $11,180 |
| Novocure Inc. | $10,025 |
| ZOLL Medical Corporation | $10,000 |
| Abbott | $9,983 |
| Jazz Pharmaceuticals Inc. | $8,500 |
| Aesculap Implant Systems, LLC | $7,800 |
| Boehringer Ingelheim International GmbH | $6,199 |
| Medline Industries LP | $5,000 |
| Astrazeneca AB | $4,700 |
| Olympus America Inc. | $4,396 |
| Novocure GmbH | $4,344 |
| Cordis Corporation | $3,919 |
| Roche Diagnostics Corporation | $3,877 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | $3,558 |
| Bioventus LLC | $2,742 |